Sullivan Papain Block McGrath Coffinas & Cannavo, P.C. Sullivan Papain Block McGrath Coffinas & Cannavo, P.C. Sullivan Papain Block McGrath Coffinas & Cannavo, P.C.
Call Today For a Free Consultation Call For a Free Consultation (212) 732-9000
New York Personal Injury Attorneys Click for free consultation

New York Personal Injury Attorney Blog

The Construction Industry’s Fatal Four

August 6, 2019 in
The construction industry’s term, the “fatal four,” refers to the four most common causes of workplace fatalities. They include falls, being struck by an object, electrocution, and individuals being caught in or pinned between objects. According to the Occupational Safety and Health Administration (OSHA),...
Continue Reading

Allergan Recalls Textured Breast Implants Linked to Rare Cancer

August 1, 2019 in
The Food and Drug Administration recently urged Allergan to recall its BIOCELL textured breast implants and tissue expanders from the global market due to concerns over a rare form of cancer. Here, the product liability attorneys at Sullivan Papain Block McGrath Coffinas & Cannavo,...
Continue Reading

SPBMC Counsel James Wilkens’ Recent Multi-Million Dollar Verdict Published in the New York Law Journal

July 30, 2019 in
The details of a multi-million dollar verdict obtained by SPBMC Counsel James Wilkens’ were recently published in the New York Law Journal. The verdict was obtained after the delivery of Wilkens’ client, Somaya McCloud, was determined to be mismanaged, causing her to suffer severe...
Continue Reading

SPBMC Partner Nicholas Papain Obtains $1.75 Million Settlement for U.S. Postal Worker in Slip-and-Fall Claim

July 26, 2019 in
SPBMC Partner Nicholas Papain recently obtained a $1.75 million settlement for a United States Post Office letter carrier who sustained a significant ankle injury after he fell on ice on a homeowner’s driveway.  Mr. Papain’s client, a 40-year-old letter carrier, was delivering mail the...
Continue Reading

Pfizer Inc. Allegedly Hid Risks of Sepsis & Amputation on Xeljanz Labels; FDA Approves “Black Box” Warnings for the Drug

July 25, 2019 in
A recent lawsuit alleges that Pfizer Inc., the manufacturer of widely used arthritis drug Xeljanz, failed to warn U.S. customers that the drug can cause sepsis leading to amputation. After reviewing initial findings from recent clinical trials of the drug, the Food and Drug...
Continue Reading